AVANÇOS NO DIAGNÓSTICO PRECOCE E NO MANEJO MULTIPROFISSIONAL DAS NEOPLASIAS TROFOBLÁSTICAS GESTACIONAIS: UM DESAFIO PARA A OBSTETRÍCA MODERNA
DOI:
https://doi.org/10.36557/2674-8169.2025v7n9p1267-1277Keywords:
Public health policies, Early screening, Cervical cancer, Breast cancerAbstract
Gestational trophoblastic neoplasms (GTNs) represent a spectrum of diseases arising from trophoblastic tissue, ranging from hydatidiform mole to malignant forms such as choriocarcinoma. Although rare, they carry high morbidity and mortality when not diagnosed early. With advances in diagnostic techniques, such as serial measurement of human chorionic gonadotropin (β-hCG) and the use of high-resolution ultrasound, a significant transformation has occurred in the prognosis of these patients. In this context, understanding the advances in early diagnosis and in multiprofessional management has become essential for modern obstetrics, which faces the challenge of ensuring comprehensive and effective maternal care. The aim of this study was to analyze the progress achieved in early diagnosis and in multiprofessional management of GTNs, highlighting their relevance to current clinical practice. To this end, a narrative literature review was conducted, based on scientific articles available in the PubMed, SciELO, and LILACS databases, published between 2020 and 2025, using the descriptors “gestational trophoblastic neoplasia,” “early diagnosis,” “multiprofessional management,” and “obstetrics.” Original studies, systematic reviews, and recent clinical guidelines were included. The analysis results demonstrated that early diagnosis, combined with β-hCG monitoring and risk stratification, reduces complications and guides individualized approaches. Standardized protocols from organizations such as FIGO and WHO have established safe criteria for treatment selection, ranging from single-agent chemotherapy to multi-agent regimens for more severe cases. Furthermore, multiprofessional management has proven to be decisive not only for therapeutic success but also for the emotional and social follow-up of patients, with the integrated participation of obstetricians, oncologists, pathologists, psychologists, and nursing teams. Recent studies also highlight that rehabilitation and psychosocial support contribute to better treatment adherence and improved quality of life after clinical outcomes. It is concluded that advances in early diagnosis and multiprofessional management have revolutionized obstetric practice in the field of GTNs, raising cure rates to over 90% in specialized centers. However, challenges remain, especially regarding inequality in access to diagnostic and therapeutic resources in developing countries. Therefore, it is necessary to expand professional training, consolidate integrated protocols, and strengthen public policies that ensure universal and equitable access to treatment, thus guaranteeing the continuity of progress achieved in this area.
Downloads
References
ALBRIGHT, B. B. et al. Treatments and outcomes in high‐risk gestational trophoblastic neoplasia: A systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology, v. 130, n. 5, p. 443–453, 25 jan. 2023.
BOARD, E. Gestational Trophoblastic Disease Treatment (PDQ®). Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK132724/. Acesso em: 24 ago. 2024.
BOARD, E. Gestational Trophoblastic Disease Treatment (PDQ®). Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK65977/. Acesso em: 24 ago. 2024.
BUZA, N.; HUI, P. Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine. Modern Pathology, v. 34, n. 9, p. 1658–1672, 1 set. 2021.
CLARK, J. J.; SLATER, S.; SECKL, M. J. Treatment of gestational trophoblastic disease in the 2020s. Current Opinion in Obstetrics & Gynecology, v. 33, n. 1, p. 7–12, 15 dez. 2020.
ELHAM SAFFARIEH; SEYEDEHYOUSEFI, R. A review on management of gestational trophoblastic neoplasia. Journal of Family Medicine and Primary Care, v. 9, n. 3, p. 1287–1287, 1 jan. 2020.
GONZALEZ, J. et al. Gestational Trophoblastic Disease: Complete versus Partial Hydatidiform Moles. Diseases, v. 12, n. 7, p. 159–159, 17 jul. 2024.
JARETT VANZ-BRIAN PEREIRA; LIM, T. Hyperthyroidism in gestational trophoblastic disease – a literature review. Thyroid Research, v. 14, n. 1, 14 jan. 2021.
JOYCE, C. M. et al. Advances in the diagnosis and early management of gestational trophoblastic disease. BMJ Medicine, v. 1, n. 1, p. e000321–e000321, 1 dez. 2022.
KAUR, B. et al. Expert pathology for GTD: towards an international multidisciplinary team meeting (MDT). Gynecologic and Obstetric Investigation, 8 jan. 2024.
KAMIJO, K. et al. Efficacy and Safety of the Surgery-First Approach Compared to the Chemotherapy-First Approach for Treating Low-Risk Gestational Trophoblastic Neoplasia: A Systematic Review and Meta-Analysis. Cureus, 21 set. 2023.
LUKINOVIC, N. et al. Advances in diagnostics and management of gestational trophoblastic disease. Radiology and Oncology, v. 56, n. 4, p. 430–439, 27 out. 2022.
NGU, S.-F.; NGAN, H. Y. S. Surgery including fertility-sparing treatment of GTD. Best Practice & Research Clinical Obstetrics & Gynaecology, v. 74, p. 97–108, 1 jul. 2021.
SOPER, J. T. Gestational Trophoblastic Disease. Obstetrics and Gynecology, v. 137, n. 2, p. 355–370, 5 jan. 2021
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Benedito Caldeira Rodrigues Neto , Ana Beatriz Oliveira de Melo , Maria Eduarda Ferreira Lima , Yasmim Freitas Leal , Maria Milene Pastana Vieira , Jhennyfer Raiane da Costa Gusmão , Camily Vitória Ramos da Silva , Lorena Beatriz Santos Santos , Naylane de Farias Caldas , Rosalina de Paula Furtado , Joaquim Gabriel Lima dos Santos , Soraya Wellen Costa Ribeiro

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



